Objective: Currently, Buyang Huanwu Decoction (BHD) used alone or integrated with Western drugs has been widely used as an alternative and effective method for the treatment of stroke of sequelae in China. Many clinical studies reported the effectiveness ranging from case reports and case series to controlled observational studies and randomized clinical trials, but the evidence for its effect is not clear. Our objective was to evaluate the clinical efficacy of Buyang Huanwu decoction (BHD) in treating sequelae of stroke.
